Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

n thousands, except per share information)(Unaudited)Three Months EndedSix Months EndedJune 30, June 30,2014201320142013Revenue:Product sales and royalty revenue

$
5,891
$
,675
$
,808
$
22,810
Non-cash royalty revenue related to sale of future royalties

4,8373,82810,6108,221License, collaboration and other revenue

17,78519,35925,86625,835Total revenue28,51333,86248,28456,866Operating costs and expenses:Cost of goods sold5,1085,01113,01516,672Research and development36,70252,23075,04097,848General and administrative9,6199,22619,54720,057Total operating costs and expenses

51,42966,467107,602134,577Loss from operations(22,916)(32,605)(59,318)

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Inc. (NYSE: CRY ), a leading medical ... vascular surgery, announced today that James Patrick (Pat) ... elected to the Company,s Board of Directors, effective October ... Executive Chairman of CryoLife, stated, "Since joining the Company in ... who is well positioned to maximize CryoLife,s potential.  His ...
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
(Date:10/22/2014)... , Oct. 21, 2014  Early symptoms of ... or unnoticed, but new technology, coupled with yearly, ... leading to earlier detection of eye diseases, including ... million Americans. If left untreated, these diseases can ... Recently, optometric researchers have deployed ...
Breaking Medicine Technology:Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
(Date:10/22/2014)... 22, 2014 Healthcare professionals who ... continuing education at home or on-the-go via laptops, ... 20 brand new, premium Seminar-on-Demand CE courses. The ... over 2,000 hours of CE course ... educational experience. With such a diverse library, there’s ...
(Date:10/22/2014)... are only 24 hours in a day, that doesn’t seem to ... within their busy schedules for exercise and fitness. Fortunately, one does ... in shape. Here are five ways you can reach your fitness ... Your Commute , Consider riding a bike or taking the bus ... routine. If you must use your car to get to work, ...
(Date:10/22/2014)... 2014 Richard Carlson, Managing Partner of ... with over 25 years experience. Mr. Carlson is ... areas related to EDI, B2B Commerce, RFID and Internet/Intranet ... Advisory Board member for Pharmaceutical Commerce Magazine and a ... Group is a management and technology consulting firm focused ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... length may be showing a genetic propensity for obesity as ... have been linked to increased body fat, but the same ... muscle, the researchers said. At 1 year, kids with ... and 3, however, these genes were linked to excessive weight ...
(Date:10/22/2014)... Two sisters in high school have developed ways to ... Krishen use electronic stethoscopes, which electronically amplify body sounds, ... or heartbeats. Ilina, a senior at Port Huron ... way to detect early lung damage in people exposed ... recorded one breath cycle each from 16 smokers, 25 ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... ... Alliance provides real estate services to corporate tenants and users of commercial real ... ... (ITRA), whose members specialize in tenant representation , most commercial tenants have ...
... The ... UV printing applications in Guangzhou. , ... (PRWEB) March 8, 2010 -- Printing South China / Sino Label 2010 in Guangzhou ... UV printing applications . The Phoseon Technology exhibit (Stand 5411) will highlight Phoseon’s large ...
... of Utah engineers developed a computer-controlled, motorized hand and arm support ... and tools over a wider area than otherwise possible, and with ... "We,ve invented a new device the ... tasks with their hands such as surgery, painting, electronics repair or ...
... with potential exposure to high levels of sunlight have a ... less likely to be exposed to sunlight at work. The ... and kidney cancer risk in women. Published early online in ... study is the largest case-control study of kidney cancer to ...
... Andrew Whitelaw, Professor of Neonatal Medicine at the University of ... Trust, has shown that, after a haemorrhage, the fluid inside ... In 1998, Professor Whitelaw and Ian Pople ... was "washed out" to remove the toxic substances. ...
... identified a region of a human chromosome that is ... disease. People with EoE frequently have difficulty eating or ... study further suggests that a suspected so-called master allergy ... this rare but debilitating disorder. EoE is ...
Cached Medicine News:Health News:Lease Audits Reduce Operating Costs 2Health News:Lease Audits Reduce Operating Costs 3Health News:Phoseon Technology Continues Worldwide Rollout of UV-LED Curing Systems with Attendance at Printing South China 2010 2Health News:A high-tech handrest 2Health News:A high-tech handrest 3Health News:A high-tech handrest 4Health News:A high-tech handrest 5Health News:Occupational sunlight exposure and kidney cancer risk in men 2Health News:Pioneering treatment reduces disability in premature babies with serious brain hemorrhage 2Health News:Pioneering treatment reduces disability in premature babies with serious brain hemorrhage 3Health News:Pioneering treatment reduces disability in premature babies with serious brain hemorrhage 4Health News:NIAID media availability: Food allergy-related disorder linked to master allergy gene 2
Epilation forceps straight ends size 3.5"....
Forceps, extra delicate, straight....
Jewelers Forceps, delicate, straight....
Jewelers Forceps, standard, straight....
Medicine Products: